UroGen Pharma (URGN) announced that the Centers for Medicare and Medicaid Services, CMS, has assigned a permanent Healthcare Common Procedure ...
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that the Centers for ...
No other Telix product has received a marketing authorization in any jurisdiction. 2 Healthcare Common Procedure Coding System. 3 Telix ASX disclosure 23 September 2025. 4 All European countries ...